Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfapump DSR in Heart Failure with Persistent Congestion
NCT04882358Unknown
- Sponsor
- Sequana Medical
- Start
- May 2021
- Primary completion
- Aug 2022
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Sequana Medical. Primary endpoints: Treatment related Serious Adverse Events at Day 156 and Device related Serious Adverse Events at Day 156. Status: unknown.
Beyond the preview
Go deeper on NCT04882358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04882358.